发布求助
文献互助 智能选刊 最新文献

Medicina Interna de Mexico最新文献

筛选
英文 中文
Púrpura de Henoch-Schönlein como manifestación inicial de mieloma múltiple 过敏性紫癜作为多发性骨髓瘤的首发表现
Medicina Interna de Mexico Pub Date : 2018-06-24 DOI: 10.24245/mim.v34i4.1579
L. F. Pineda-Galindo, Leslie Moranchel-García, Magdalena Sánchez-Uribe, P. Ramírez-Mendoza, O. Vera-Lastra
{"title":"Púrpura de Henoch-Schönlein como manifestación inicial de mieloma múltiple","authors":"L. F. Pineda-Galindo, Leslie Moranchel-García, Magdalena Sánchez-Uribe, P. Ramírez-Mendoza, O. Vera-Lastra","doi":"10.24245/mim.v34i4.1579","DOIUrl":"https://doi.org/10.24245/mim.v34i4.1579","url":null,"abstract":"","PeriodicalId":35750,"journal":{"name":"Medicina Interna de Mexico","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"47778541","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Agonistas de GLP-1 más inhibidores de SGLT2. ¿Efectos cardioprotectores aditivos? GLP-1激动剂加SGLT2抑制剂。添加剂的心脏保护作用？
Medicina Interna de Mexico Pub Date : 2018-06-24 DOI: 10.24245/mim.v34i4.1862
Gabriel Jaime Matta-Herrera, Luis Manuel Ballestas-Alarcón, A. Ramirez-Rincón
{"title":"Agonistas de GLP-1 más inhibidores de SGLT2. ¿Efectos cardioprotectores aditivos?","authors":"Gabriel Jaime Matta-Herrera, Luis Manuel Ballestas-Alarcón, A. Ramirez-Rincón","doi":"10.24245/mim.v34i4.1862","DOIUrl":"https://doi.org/10.24245/mim.v34i4.1862","url":null,"abstract":"In South America, Colombia is secondly with number of diagnosed patients with diabetes mellitus (DM) and probably non-diagnostic patients. It has been calculated in Colombia 2 million people with diabetes mellitus, with a prevalence of 9.6% and it is the fifth position of causes of death and within the 10 causes that motivate the search for help. The new therapies with glucagon-like-1 receptors agonists (GLP-1 RAs) and SGLT2 inhibitors (SGLT2i) have been shown individually and through different mechanisms of action impact on the metabolic control and other variables such as blood pressure, lipid profile, weight, renal and cardiovascular protection. Type 2 diabetes mellitus treatment guides recommend for patients with dual therapy who continue HA1c out of goals, consider triple therapy if the patient has not achieved the goals after three months. A systematic search was made that included search engines such as Pubmed, Embase and Cochrane, resulting in 12 articles. More clinical studies should be done with the combination of GLP-1 RAs and SGLT2i in the context of patients with type 2 diabetes mellitus with poor metabolic control despite dual and triple therapies.","PeriodicalId":35750,"journal":{"name":"Medicina Interna de Mexico","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48094117","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
El Consejo Mexicano de Medicina Interna, AC. Gestión 2015-2018. Rendición de cuentas y transparencia. Informe y análisis 墨西哥内科委员会，AC。2015-2018年管理。问责制和透明度。报告和分析
Medicina Interna de Mexico Pub Date : 2018-06-24 DOI: 10.24245/MIM.V34I4.2279
R. López-Espinosa, Alpha Escamilla-Ruiz, Carlos Lijtszain-Sklar
{"title":"El Consejo Mexicano de Medicina Interna, AC. Gestión 2015-2018. Rendición de cuentas y transparencia. Informe y análisis","authors":"R. López-Espinosa, Alpha Escamilla-Ruiz, Carlos Lijtszain-Sklar","doi":"10.24245/MIM.V34I4.2279","DOIUrl":"https://doi.org/10.24245/MIM.V34I4.2279","url":null,"abstract":"","PeriodicalId":35750,"journal":{"name":"Medicina Interna de Mexico","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44453388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cartílago de tiburón: una panacea oncológica más 鲨鱼软骨:肿瘤的灵丹妙药
Medicina Interna de Mexico Pub Date : 2018-06-24 DOI: 10.24245/MIM.V34I4.2041
Guillermo Murillo-Domínguez
{"title":"Cartílago de tiburón: una panacea oncológica más","authors":"Guillermo Murillo-Domínguez","doi":"10.24245/MIM.V34I4.2041","DOIUrl":"https://doi.org/10.24245/MIM.V34I4.2041","url":null,"abstract":"","PeriodicalId":35750,"journal":{"name":"Medicina Interna de Mexico","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48658155","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Diferencias en el grosor de la grasa epicárdica en pacientes con diabetes mellitus tipo 2, prediabetes y sujetos no diabéticos 2型糖尿病患者、糖尿病前期和非糖尿病受试者心外膜脂肪厚度的差异
Medicina Interna de Mexico Pub Date : 2018-06-24 DOI: 10.24245/mim.v34i4.1969
Karla C Arana-Pazos, D. R. Benítez-Maldonado, Iván Meneses-Acero, Jorge Luis Narváez-Rivera, Carolina Guerrero-García, A. Rubio-Guerra
{"title":"Diferencias en el grosor de la grasa epicárdica en pacientes con diabetes mellitus tipo 2, prediabetes y sujetos no diabéticos","authors":"Karla C Arana-Pazos, D. R. Benítez-Maldonado, Iván Meneses-Acero, Jorge Luis Narváez-Rivera, Carolina Guerrero-García, A. Rubio-Guerra","doi":"10.24245/mim.v34i4.1969","DOIUrl":"https://doi.org/10.24245/mim.v34i4.1969","url":null,"abstract":"","PeriodicalId":35750,"journal":{"name":"Medicina Interna de Mexico","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"68825672","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Mortalidad por enfermedad renal crónica y su relación con la diabetes en México 墨西哥慢性肾脏疾病死亡率及其与糖尿病的关系
Medicina Interna de Mexico Pub Date : 2018-06-24 DOI: 10.24245/MIM.V34I4.1877
Ja Aldrete-Velasco, E. Chiquete, Ja. Rodríguez-García, R. Rincón-Pedrero, R. Correa-Rotter, R. García-Peña, E. Perusquía-Frías, JC Dávila‐Valero, C. Reyes-Zavala, J. Pedraza-Chávez
{"title":"Mortalidad por enfermedad renal crónica y su relación con la diabetes en México","authors":"Ja Aldrete-Velasco, E. Chiquete, Ja. Rodríguez-García, R. Rincón-Pedrero, R. Correa-Rotter, R. García-Peña, E. Perusquía-Frías, JC Dávila‐Valero, C. Reyes-Zavala, J. Pedraza-Chávez","doi":"10.24245/MIM.V34I4.1877","DOIUrl":"https://doi.org/10.24245/MIM.V34I4.1877","url":null,"abstract":"","PeriodicalId":35750,"journal":{"name":"Medicina Interna de Mexico","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"46064490","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Evolución de la definición del síndrome de insuficiencia respiratoria aguda 急性呼吸衰竭综合征定义的演变
Medicina Interna de Mexico Pub Date : 2018-06-24 DOI: 10.24245/mim.v34i4.2092
R. Carrillo-Esper, M. D. J. Sánchez-Zúñiga, Nikolett I. Medveczky-Ordoñez, D. M. Carrillo-Córdova
{"title":"Evolución de la definición del síndrome de insuficiencia respiratoria aguda","authors":"R. Carrillo-Esper, M. D. J. Sánchez-Zúñiga, Nikolett I. Medveczky-Ordoñez, D. M. Carrillo-Córdova","doi":"10.24245/mim.v34i4.2092","DOIUrl":"https://doi.org/10.24245/mim.v34i4.2092","url":null,"abstract":"Acute respiratory distress syndrome (ARDS) is an acute diffuse, inflammatory lung injury, leading to increased pulmonary vascular permeability, increased lung weight, loss of aerated lung tissue, hypoxemia, bilateral radiographic infiltrates, increased physiological dead space and intrapulmonary shunt and decrease lung compliance. ARDS was first described by Ashbaugh and Petty in 1967. For more than 20 years, there was no common definition of ARDS, and inconsistent definitions led to confusion and misdiagnosis. The 1994 The American European Consensus Conference (AECC) definition become accepted but had important limitations, since then, issues regarding the reliability and validity of this definition have emerged. The current definition is the Berlin one. This definition seems to be more accurate than the AECC definition and may facilitate prompt recognition of ARDS and promote protective ventilation strategy. The aim of this paper is to make a brief review of the evolution of the definition of ARDS at 50 years of its description.","PeriodicalId":35750,"journal":{"name":"Medicina Interna de Mexico","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"45546478","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Probióticos ¿coadyuvantes en el tratamiento médico? 益生菌是否有助于医疗？
Medicina Interna de Mexico Pub Date : 2018-06-24 DOI: 10.24245/mim.v34i4.1878
Parménides Guadarrama-Ortíz, J. C. Flores-Vázquez, Martha Carnalla-Cortés, J. A. Choreño-Parra
{"title":"Probióticos ¿coadyuvantes en el tratamiento médico?","authors":"Parménides Guadarrama-Ortíz, J. C. Flores-Vázquez, Martha Carnalla-Cortés, J. A. Choreño-Parra","doi":"10.24245/mim.v34i4.1878","DOIUrl":"https://doi.org/10.24245/mim.v34i4.1878","url":null,"abstract":"","PeriodicalId":35750,"journal":{"name":"Medicina Interna de Mexico","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48948841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Asociación entre la severidad de la depresión y el apego al primer esquema de tratamiento antirretroviral 抑郁的严重程度与第一个抗逆转录病毒治疗方案的依从性之间的关系
Medicina Interna de Mexico Pub Date : 2018-06-24 DOI: 10.24245/mim.v34i4.1828
M. López-Hernández, Patricia Montoya-Escutia
{"title":"Asociación entre la severidad de la depresión y el apego al primer esquema de tratamiento antirretroviral","authors":"M. López-Hernández, Patricia Montoya-Escutia","doi":"10.24245/mim.v34i4.1828","DOIUrl":"https://doi.org/10.24245/mim.v34i4.1828","url":null,"abstract":"OBJECTIVE: To compare the rate of adherence to antiretroviral therapy in the first line in patients with depressive disorders vs those without depression. MATERIAL AND METHOD: A prospective study was done from January to June 2016 in patients from the HIV clinics of the Regional General Hospital No. 1 of IMSS, and the General Hospital Tacuba, in antiretroviral treatment with a first scheme, started more than six months ago, excluding patients with neurological disorders, different from depression, patients with diagnosis and/or previous treatment of depression. Patients answered the Beck questionnaire for depression and the SMAQ scale for adherence. RESULTS: 180 patients were evaluated with a first antiretroviral treatment regimen. It was found that 126 (70%) patients did not present depression, 36 (20%) presented depression, 15 (8.3%) presented moderate depression and 3 (1.7%) presented severe depression. Non-adherence was observed in 15.8% of patients without depression versus 55.5% of patients with depression (p = 0.01). The adherence of patients with depression was inversely proportional to the severity of the same. Regarding the viral load under the limit of suppression (< 40 copies/mL) in patients without depression, a higher proportion of patients with a viral load higher than 40 copies/mL was observed: 17.4% vs 15.8%, considered non-adherent by the SMAQ questionnaire. CONCLUSIONS: Adherence decreases with the severity of depression in patients, putting the effectiveness of antiretroviral treatment at risk.","PeriodicalId":35750,"journal":{"name":"Medicina Interna de Mexico","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"44996481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Fármacos diuréticos: alteraciones metabólicas y cardiovasculares en el adulto mayor 利尿剂：老年人代谢和心血管疾病
Medicina Interna de Mexico Pub Date : 2018-06-24 DOI: 10.24245/MIM.V34I4.1684
J. E. Cruz-Aranda
{"title":"Fármacos diuréticos: alteraciones metabólicas y cardiovasculares en el adulto mayor","authors":"J. E. Cruz-Aranda","doi":"10.24245/MIM.V34I4.1684","DOIUrl":"https://doi.org/10.24245/MIM.V34I4.1684","url":null,"abstract":"","PeriodicalId":35750,"journal":{"name":"Medicina Interna de Mexico","volume":"1 1","pages":""},"PeriodicalIF":0.0,"publicationDate":"2018-06-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"41587636","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信